15573-98-5 Usage
Description
(1,3-dioxohexahydro-4,7-epoxy-2-benzofuran-4(1H)-yl)methyl acetate is a complex chemical compound derived from benzofuran, a heterocyclic compound with potential applications in various industries. As a benzofuran derivative, it may possess properties that make it a promising candidate for pharmaceutical and agrochemical uses.
Used in Pharmaceutical Industry:
(1,3-dioxohexahydro-4,7-epoxy-2-benzofuran-4(1H)-yl)methyl acetate is used as a potential therapeutic agent for various conditions due to the known anti-cancer, anti-inflammatory, and antiviral properties of benzofuran derivatives. Its specific structure may contribute to its efficacy in treating these conditions.
Used in Agrochemical Industry:
In the agrochemical industry, (1,3-dioxohexahydro-4,7-epoxy-2-benzofuran-4(1H)-yl)methyl acetate may be utilized as a component in the development of pesticides or other chemical products for agricultural use, leveraging the compound's potential bioactivity.
Used as a Solvent or Intermediate in Organic Synthesis:
The presence of the acetate group in (1,3-dioxohexahydro-4,7-epoxy-2-benzofuran-4(1H)-yl)methyl acetate suggests that it could be used as a solvent or an intermediate in organic synthesis processes, contributing to the synthesis of other complex organic compounds.
Further research and investigation are necessary to fully explore the properties and potential uses of (1,3-dioxohexahydro-4,7-epoxy-2-benzofuran-4(1H)-yl)methyl acetate, as its significance and applications may extend beyond the current understanding.
Check Digit Verification of cas no
The CAS Registry Mumber 15573-98-5 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,5,5,7 and 3 respectively; the second part has 2 digits, 9 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 15573-98:
(7*1)+(6*5)+(5*5)+(4*7)+(3*3)+(2*9)+(1*8)=125
125 % 10 = 5
So 15573-98-5 is a valid CAS Registry Number.
15573-98-5Relevant articles and documents
Structure-based design of a highly selective catalytic site-directed inhibitor of Ser/Thr protein phosphatase 2B (calcineurin)
Baba, Yoshiyasu,Hirukawa, Nozomu,Tanohira, Naoto,Sodeoka, Mikiko
, p. 9740 - 9749 (2007/10/03)
Protein serine/threonine phosphatases (PP1, PP2A and PP2B) play important roles in intracellular signal transductions. The immunosuppressant drugs FK506 and cyclosporin A (CsA) bind to immunophilins, and these complexes selectively inhibit PP2B (calcineurin), leading to the suppression of T-cell proliferation. Both FK506 and CsA must, however, form complexes with immunophilins to exert their inhibitory action on PP2B. Thus, it is of interest to find a direct and selective inhibitor of PP2B that does not involve the immunophilins as a biological tool for studies of PP2B and also as a candidate therapeutic agent. We selected the simple natural product cantharidin, a known PP2A-selective inhibitor, as a lead compound for this project. Primary SAR indicated that norcantharidin (7-oxabicyclo[2.2.1]heptane-2,3-dicarboxylic anhydride) inhibits not only PP1 and PP2A but also PP2B, and a binding model of norcantharidin carboxylate to the PP2B catalytic site was computationally constructed. Based on this binding model, we designed and synthesized several cantharidin derivatives. Among these compounds, 1,5-dibenzoyloxymethyl-substituted norcantharidin was found to inhibit PP2B without inhibiting PP1 or PP2A. To our knowledge, this is the first highly selective catalytic site-directed inhibitor of PP2B.
